Wed May 01 2024

  • “Institutional Review Board (IRB) and the Protocol Review and Monitoring Committee (PRMC) – What’s the Difference?”
    1:00pm - 1:00pm
    HSRF room 300

    For researchers who intend to recruit cancer patients from cancer-focused clinics, or the primary aim of the study is related to cancer (the diagnosis, screening, treatment, or prevention of cancer; risk factors associated with the development or survivorship of cancer; data and/or biological specimens from cancer patients) this session will review the fundamental differences and regulatory mandates required for each committee’s reviews.

    Revised date/time - Wednesday May 1, 2024

    1:00- 2:00 HSRF<!m/316672> room 300

    Presented by: Melanie Locher, B.S., IRB Director & Christa Varnadoe-Rothman, DNP, MSN, AGNP-C, OCN, CCRP, Director, Cancer Clinical Trials